Report indicates shift in strategy

Share this article:
A report released by Best Practices indicates that leading pharma and biopharmaceutical companies are rethinking their publication strategies, in light of new transparency guidelines.

“Traditional, global peer-reviewed journals remain the first choice of most companies at all phases of product development, but companies are increasingly exploring alternative media for scientific publications—50% of benchmark participants said they will be increasing the percentage of articles they submit to alternative media, such as e-journals, compared with 36% increasing submission to peer-reviewed journals,” said Martha Haswell, senior research analyst at Best Practices. 
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Read the complete April 2014 Digital Edition

Read the complete April 2014 Digital Edition

Click the above link to access the complete Digital Edition of the April 2014 issue of MM&M, with all text, charts and pictures.

Antidote: Are e-cigarettes safe?

Antidote: Are e-cigarettes safe?

The pros and cons of e-cigarettes

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.